Your account is not claimed yet. You can sign up with ORCID to claim your account.

Wen-Fang Cheng (Wen Fang Cheng)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Journal of gynecologic oncology

Cancer medicine

PloS one

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Po-Han Lin, Yun-Wen Tien, Wen-Fang Cheng, Ying Cheng Chiang, Chien-Huei Wu, Karen Yang, Chiun-Sheng Huang
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. Journal of gynecologic oncology (2023)
Ching-Yu Cheng, Heng-Cheng Hsu, Yi-Jou Tai, Ying-Cheng Chiang, Yu Li Chen, Wen-Fang Cheng
Outcome and prognostic factors of unexpected ovarian carcinomas. Cancer medicine (2022)
Hung Hsueh Chou, Sian Fereday, Anna De Fazio, Chih-Long Chang, David D L Bowtell, Heng Cheng Hsu, Nadia Traficante, Soo Young Jeong, Wen-Fang Cheng, Dinuka Ariyaratne, null null, Teresa Tung, Viraj Rajadhyaksha, Won-Hee Lee, David Brown, Byoung Gie Kim
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan. Journal of gynecologic oncology (2022)
Yen-Ling Lai, Chun Ju Chiang, Yu-Li Chen, San-Lin You, Yun-Yuan Chen, Ying-Cheng Chiang, Yi-Jou Tai, Heng-Cheng Hsu, Chi-An Chen, Wen-Fang Cheng
Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis. Cancer medicine 10 (19) (2021)
Chia-Ying Wu, Yi-Jou Tai, I-Lun Shih, Ying Cheng Chiang, Yu Li Chen, Heng Cheng Hsu, Wen-Fang Cheng
Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas. Cancer medicine 11 (4) (2021)
Hsiao Yun Lu, Yi-Jou Tai, Yu Li Chen, Ying Cheng Chiang, Heng Cheng Hsu, Wen-Fang Cheng
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients. Journal of gynecologic oncology 32 (2) (2020)
Yu-Li Chen, Han-Wei Lin, Chung-Liang Chien, Yen-Ling Lai, Wei-Zen Sun, Chi-An Chen, Wen-Fang Cheng
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. Journal for immunotherapy of cancer 7 (1) (2019)
Yi-Jou Tai, Yun Yuan Chen, Huang Cheng Hsu, Chun Ju Chiang, San-Lin You, Chi An Chen, Wen-Fang Cheng, null null
Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study. Journal of gynecologic oncology 29 (4) (2018)
Lin-Chau Chang, Chih-Fen Huang, Mei-Shu Lai, Li-Jiuan Shen, Fe-Lin Lin Wu, Wen-Fang Cheng
Prognostic factors in epithelial ovarian cancer: A population-based study. PloS one 13 (3) (2018)
Hung-Chun Fu, Jen Ruei Chen, Min Yu Chen, Keng-Fu Hsu, Wen-Fang Cheng, An Jen Chiang, Yu Min Ke, Yu Chieh Chen, Yin Yi Chang, Chia Yen Huang, Chieh Yi Kang, Yuan Yee Kan, Sheng Mou Hsiao, Ming Shyen Yen
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study. Journal of gynecologic oncology 29 (5) (2018)
Chien An Chen, Chun Ju Chiang, Yun-Yuan Chen, San-Lin You, Shu Feng Hsieh, Chao Hsiun Tang, Wen-Fang Cheng
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens. Journal of gynecologic oncology 29 (1) (2018)
Heng Cheng Hsu, Yi-Jou Tai, Yu-Li Chen, Ying-Cheng Chiang, Chi-An Chen, Wen-Fang Cheng
Factors predicting parametrial invasion in patients with early-stage cervical carcinomas. PloS one 13 (10) (2018)

Wen-Fang Cheng.css-eqlu8i{font-size:small;padding-left:4px;} (Wen Fang Cheng)

Publication Activity (10 Years)

Top Topics

Top Venues

Wen-Fang Cheng (Wen Fang Cheng)